JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258905

Human HNRNPDL knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

HNRNPDL KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 38 bp deletion in exon 1 and 47 bp deletion in exon 1.

View Alternative Names

A+U-rich element RNA binding factor, AA407431, AA959857, AU-rich element RNA-binding factor, D5Ertd650e, D5Wsu145e, HNRDL_HUMAN, HNRNP, Heterogeneous nuclear ribonucleoprotein D like protein, Heterogeneous nuclear ribonucleoprotein D-like, JKT41-binding protein, JKTBP, JKTBP2, MGC125262, Protein laAUF1, hnHNRP DL, hnRNP D-like, hnRNP DL, hnRPD like protein, laAUF1

2 Images
Sanger Sequencing - Human HNRNPDL knockout HeLa cell lysate (AB258905)
  • Sanger seq

Unknown

Sanger Sequencing - Human HNRNPDL knockout HeLa cell lysate (AB258905)

Allele-1 : 47 bp deletion in exon 1

Sanger Sequencing - Human HNRNPDL knockout HeLa cell lysate (AB258905)
  • Sanger seq

Unknown

Sanger Sequencing - Human HNRNPDL knockout HeLa cell lysate (AB258905)

Allele-2 : 38 bp deletion in exon 1

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 38 bp deletion in exon 1 and 47 bp deletion in exon 1.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258905-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human HNRNPDL knockout HeLa cell lysate", "number":"AB258905-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258905-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
HNRNPDL
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HNRPDL also known as heterogeneous nuclear ribonucleoprotein D-like is a protein with a mass of about 42 kDa. It plays an important role in RNA processing activities like splicing transportation stabilization and degradation. The protein is part of the hnRNP family which contains versatile nucleic acid-binding proteins involved in various aspects of mRNA processing and metabolism. HNRPDL is expressed in multiple tissues including high levels in muscle heart and brain indicating its broad functional importance.
Biological function summary

HnRNP D-like protein participates in regulating gene expression post-transcriptionally. It often forms a complex with other hnRNP proteins enabling the modulation of RNA metabolic processes. This protein binds to RNA through its nucleic acid-binding domains influencing the mRNA stability and pre-mRNA processing. It affects various cellular processes by regulating gene transcripts vital for maintaining normal cellular functions.

Pathways

HnRNP D-like protein is part of key processes that influence mRNA splicing and transport. It is involved in the mRNA surveillance pathway that monitors and degrades abnormal mRNA molecules. HNRPDL also interacts with other proteins like HNRNPA1 in these pathways showing its importance in RNA regulation and cellular homeostasis. Its function in these pathways suggests it plays a role in ensuring the accuracy of mRNA synthesis and processing.

Altered HNRPDL function is linked to conditions such as myopathy and some neurodegenerative diseases. Mutations or dysregulation in hnRNP D-like protein can affect muscle tissues and might contribute to muscle degeneration disorders. Additionally its abnormal function may also relate to neurological disorders potentially through pathways that involve other hnRNP family members like HNRNPA1. Understanding its connection to these diseases could provide insights into potential therapeutic targets for related conditions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com